U.S. court awards Edwards damages in Medtronic patent fight
(Reuters) - Medtronic Inc said a U.S. jury ruled that its heart valve implant infringed a patent held by Edward Lifesciences Corp and awarded Edwards $392.5 million in damages.
Medtronic said it would appeal the ruling made by a jury in the Federal District Court of Delaware.
The medical device maker said it would oppose any request for an injunction by Edwards.
Medtronic said it expected U.S. approval for the CoreValve heart implant system by the end of its fiscal year ending April 2014.
Edwards shares rose as much as 4 percent to $73.42 on Wednesday on the New York Stock Exchange. Medtronic shares were up slightly at $59.64.
(The story corrects time period in paragraph 4 to end of fiscal year from end 2014)
(Reporting by Vrinda Manocha in Bangalore; Editing by Kirti Pandey)
- Mexican train derails, stranding 1,300 migrants headed toward U.S.
- Israeli strikes kill more Palestinians; rocket causes huge blaze in Israel |
- Man suspected of shooting six dead in Texas to appear in court
- Four servicemen, five miners killed in eastern Ukraine |
- Obama tells Israel U.S. ready to help end hostilities
Robert Blendon of the Harvard School of Public Health says the Affordable Care Act's unpopularity in 12 key states will keep it a central issue in the 2014 elections. Video